Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

10.2174/0929867311320100001

Saved in:

Bibliographic Details
Main Authors:	Ho, H.K., Németh, G., Ng, Y.R., Pang, E., Szántai-Kis, C., Zsákai, L., Breza, N., Greff, Z., Horváth, Z., Pató, J., Szabadkai, I., Szokol, B., Baska, F., Orfi, L., Ullrich, A., Kéri, G., Chua, B.T.
Other Authors:	PHARMACY
Format:	Article
Published:	2014
Subjects:	FGFR4 Inhibitor Phosphorylation Tyrosine Kinase
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/105815
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-105815
record_format	dspace
spelling	sg-nus-scholar.10635-1058152024-11-10T09:17:19Z Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing Ho, H.K. Németh, G. Ng, Y.R. Pang, E. Szántai-Kis, C. Zsákai, L. Breza, N. Greff, Z. Horváth, Z. Pató, J. Szabadkai, I. Szokol, B. Baska, F. Orfi, L. Ullrich, A. Kéri, G. Chua, B.T. PHARMACY FGFR4 Inhibitor Phosphorylation Tyrosine Kinase 10.2174/0929867311320100001 Current Medicinal Chemistry 20 10 1203-1217 CMCHE 2014-10-29T01:51:07Z 2014-10-29T01:51:07Z 2013-04 Article Ho, H.K.,Németh, G.,Ng, Y.R.,Pang, E.,Szántai-Kis, C.,Zsákai, L.,Breza, N.,Greff, Z.,Horváth, Z.,Pató, J.,Szabadkai, I.,Szokol, B.,Baska, F.,Orfi, L.,Ullrich, A.,Kéri, G.,Chua, B.T. (2013-04). Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing. Current Medicinal Chemistry 20 (10) : 1203-1217. ScholarBank@NUS Repository. <a href="https://doi.org/10.2174/0929867311320100001" target="_blank">https://doi.org/10.2174/0929867311320100001</a> 09298673 http://scholarbank.nus.edu.sg/handle/10635/105815 NOT_IN_WOS Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	FGFR4 Inhibitor Phosphorylation Tyrosine Kinase
spellingShingle	FGFR4 Inhibitor Phosphorylation Tyrosine Kinase Ho, H.K. Németh, G. Ng, Y.R. Pang, E. Szántai-Kis, C. Zsákai, L. Breza, N. Greff, Z. Horváth, Z. Pató, J. Szabadkai, I. Szokol, B. Baska, F. Orfi, L. Ullrich, A. Kéri, G. Chua, B.T. Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
description	10.2174/0929867311320100001
author2	PHARMACY
author_facet	PHARMACY Ho, H.K. Németh, G. Ng, Y.R. Pang, E. Szántai-Kis, C. Zsákai, L. Breza, N. Greff, Z. Horváth, Z. Pató, J. Szabadkai, I. Szokol, B. Baska, F. Orfi, L. Ullrich, A. Kéri, G. Chua, B.T.
format	Article
author	Ho, H.K. Németh, G. Ng, Y.R. Pang, E. Szántai-Kis, C. Zsákai, L. Breza, N. Greff, Z. Horváth, Z. Pató, J. Szabadkai, I. Szokol, B. Baska, F. Orfi, L. Ullrich, A. Kéri, G. Chua, B.T.
author_sort	Ho, H.K.
title	Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
title_short	Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
title_full	Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
title_fullStr	Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
title_full_unstemmed	Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
title_sort	developing fgfr4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/105815
_version_	1821225754520715264

Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

Similar Items